N-{4-Cyclobutyl-5-[2-(piperidin-1-yl)ethyl]-1,3-thiazol-2-yl}-1-(5-fluoropyridin-2-yl)-3-methyl-1H-pyrazole-4-carboxamide dihydrochloride

ID: ALA4465116

Chembl Id: CHEMBL4465116

PubChem CID: 155530853

Max Phase: Preclinical

Molecular Formula: C24H31Cl2FN6OS

Molecular Weight: 468.60

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nn(-c2ccc(F)cn2)cc1C(=O)Nc1nc(C2CCC2)c(CCN2CCCCC2)s1.Cl.Cl

Standard InChI:  InChI=1S/C24H29FN6OS.2ClH/c1-16-19(15-31(29-16)21-9-8-18(25)14-26-21)23(32)28-24-27-22(17-6-5-7-17)20(33-24)10-13-30-11-3-2-4-12-30;;/h8-9,14-15,17H,2-7,10-13H2,1H3,(H,27,28,32);2*1H

Standard InChI Key:  MQLIWQBORGMEKD-UHFFFAOYSA-N

Associated Targets(Human)

TRPV4 Tchem Transient receptor potential cation channel subfamily V member 4 (774 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trpv4 Transient receptor potential cation channel subfamily V member 4 (137 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.60Molecular Weight (Monoisotopic): 468.2108AlogP: 4.72#Rotatable Bonds: 7
Polar Surface Area: 75.94Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.61CX Basic pKa: 8.55CX LogP: 4.71CX LogD: 3.53
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.54Np Likeness Score: -2.15

References

1. Sami Y, Morita M, Kubota H, Hirabayashi R, Seo R, Nakagawa N..  (2019)  Discovery of a novel orally active TRPV4 inhibitor: Part 1. Optimization from an HTS hit.,  27  (17): [PMID:31327678] [10.1016/j.bmc.2019.05.041]

Source